Recently diagnosed with HIV? Click here

New drug company launched

Positive Living article • Adrian Ogier • 4 December 2009
Treating HIV

The global launch of a new specialist HIV drug company happened in Australia last month.

ViiV Healthcare, established by GlaxoSmithKline (GSK) and Pfizer, can currently boast a portfolio of ten medicines with a further seven in the pipeline.

NAPWA Executive Director, Jo Watson, has welcomed the merger – commending the company for their pledge to use revenues from current treatments to fuel research and development in the HIV area.

‘It secures us a focused response now and into the future,‘ she said. ‘We will certainly ensure that the logistical links the Australian community has established with Pfizer and GSK enjoys a smooth transition across to the new company.’

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

This article was first published in the December 2009 issue of Positive Living — more than two years ago.

While the content of this was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.